OSR Health, Inc. (OSRH) vs VivoSim Labs, Inc. (VIVS)

OSR Health, Inc. and VivoSim Labs, Inc. are both Biotechnology companies. OSR Health, Inc. and VivoSim Labs, Inc. are of similar size ($4.1M and $3.9M). VivoSim Labs, Inc. grew revenue faster over the last twelve months: −21.1% against −50.2%. OSR Health, Inc. has the higher net margin (−1,093.4% vs −11,016.1%) and the lower return on invested capital (−8.19% vs 0.00%). Across the 16 metrics below, OSR Health, Inc. leads on 9 and VivoSim Labs, Inc. on 7.

Valuation

Metric OSRH VIVS Biotechnology median
P/E n/m n/m 7.88
P/S 4.00 10.29 11.47
P/B 0.06 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.05 0.74
EV/Sales 6.17 (4.61) 10.73
Earnings yield (168.18%) (2,031.82%) (28.84%)
Free cash flow yield (105.52%) (104.63%) (23.03%)

Profitability

Metric OSRH VIVS Biotechnology median
Gross margin 35.29% 100.00% 65.16%
Operating margin (933.72%) (10,116.96%) 0.00%
Net margin (1,093.41%) (11,016.07%) 0.00%
Free cash flow margin (398.26%) (1,014.29%) 0.00%
Return on equity (14.98%) (343.10%) (57.72%)
Return on assets (11.24%) (155.93%) (49.22%)
Return on invested capital (8.19%) 0.00% 0.00%

Growth

Metric OSRH VIVS Biotechnology median
Revenue growth (TTM) (50.24%) (21.13%) 5.64%
EPS growth (last fiscal year) 71.07% (214.71%) —
Revenue growth, 5-year CAGR — (43.10%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OSRH VIVS Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 0.18 1.70 4.73
Net debt to EBITDA (0.29) 0.45 0.96

Dividend

Metric OSRH VIVS Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric OSRH VIVS Biotechnology median
Market cap 4.09m 3.92m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack